Analysts Set Revolution Medicines, Inc. (NASDAQ:RVMD) Price Target at $67.08
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus rating of “Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on […]
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have been given a consensus rating of “Buy” by the twelve ratings firms that are covering the stock, MarketBeat.com reports. Twelve research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on […]
